Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 0/5 criteria met.
- ❌ Price trend failed
- ❌ Growth failed
- ❌ Debt failed
- ❌ P/E failed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2019 → 2020: -34.12%
Price change 2020 → 2021: -74.92%
Price change 2021 → 2022: -88.31%
Price change 2022 → 2023: 49.73%
Price change 2023 → 2024: -73.93%
Price change 2024 → 2025: -86.52%
Price change 2025 → 2026: -90.15%
Price change 2026 (year to date): -91.39%
Financial growth
Revenue CAGR (8 years): N/A
Earnings CAGR (8 years): N/A
Growth status: insufficient data or negative trend.
Debt
Debt-to-equity ratio: 1436000.00
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: -0.08
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 97.54% from the high over 6 months.
Excessive correction (> 20.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="PHGE" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Dividends and earnings
BiomX Inc.: dividend history, last distributions, stock splits and earnings releases.
No known dividend for this company.
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 24/03/2026 | -67.60 | -46.10 | n/a |
| 13/11/2025 | -5.51 | -3.20 | n/a |
| 13/08/2025 | 3.61 | -6.27 | n/a |
| 19/05/2025 | -3.30 | -4.20 | n/a |
| 02/04/2025 | -8.55 | -16.50 | n/a |
| 14/11/2024 | -5.89 | -6.00 | n/a |
Stock splits
| Date | Operation |
|---|---|
| 09/09/2026 | reverse split: 1 share for 10 |
| 25/11/2025 | reverse split: 1 share for 19 |
| 26/08/2024 | reverse split: 1 share for 10 |
Factual data: ex-dividend history and earnings calendar, as of 21/11/2026. A past dividend does not guarantee the next one.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about BiomX Inc.
Is BiomX Inc. stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN US09090D3017).
How many employees does BiomX Inc. have?
52 full-time employees according to the latest published profile.
Who runs BiomX Inc.?
Jonathan Eitan Solomon MBA is the company's chief executive.